rs1555339028
Variant summary
Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PVS1_Strong
The NM_001354768.3(NRL):c.448_466dupCGGGGCTGCGGGCGCGACG(p.Glu156AlafsTer71) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000139 in 1,441,636 control chromosomes in the GnomAD database, with no homozygous occurrence. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001354768.3 frameshift
Scores
Clinical Significance
Conservation
Publications
- retinitis pigmentosa 27Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
- enhanced S-cone syndromeInheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRL | NM_001354768.3 | c.448_466dupCGGGGCTGCGGGCGCGACG | p.Glu156AlafsTer71 | frameshift_variant | Exon 3 of 3 | ENST00000561028.6 | NP_001341697.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000139 AC: 2AN: 1441636Hom.: 0 Cov.: 31 AF XY: 0.00000140 AC XY: 1AN XY: 715818 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Albinism;C0235996:Elevated circulating hepatic transaminase concentration;C0600518:Choroidal neovascularization;C1853141:Slow decrease in visual acuity;C2673946:Foveal hypoplasia;C4021768:Abnormality of metabolism/homeostasis Uncertain:1
- -
not provided Uncertain:1
This sequence change creates a premature translational stop signal (p.Glu156Alafs*71) in the NRL gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 82 amino acid(s) of the NRL protein. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NRL-related conditions. ClinVar contains an entry for this variant (Variation ID: 523490). This variant disrupts a region of the NRL protein in which other variant(s) (p.Cys219Valfs*4) have been observed in individuals with NRL-related conditions (PMID: 29385733). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at